Biography and Research Information
OverviewAI-generated summary
Jordan Pilkington's research focuses on dermatological conditions, particularly cutaneous lymphomas and skin neoplasms. Pilkington has investigated the clinical presentation and management of Cutaneous T-Cell Lymphoma (CTCL), including rare cases arising post-transplant, and explored novel genetic associations in Sézary syndrome, a form of CTCL. Recent work includes a review of clinical variants of CTCL and analysis of genes related to Mycosis Fungoides. Pilkington also examines differential diagnoses for skin lesions, distinguishing between benign conditions like cysts and more serious underlying processes such as neoplasms. Collaborations include work with Sara C. Shalin, Henry Ν. C. Wong, Henry K. Wong, and Delice Kayishunge at the University of Arkansas for Medical Sciences, with whom Pilkington has co-authored multiple publications.
Metrics
- h-index: 1
- Publications: 4
- Citations: 1
Selected Publications
-
Mogamulizumab in combination improves clinical outcomes in relapsed and refractory Sézary syndrome (2025)
-
Not a Cyst: When a Cyst Obscures a More Nefarious Process (2025)
-
Cutaneous T-Cell Lymphoma (CTCL) Arising Post Kidney Transplant: A Review of Clinical Variants in the Literature (2023)
Collaboration Network
Top Collaborators
- ISID0266 - Analysis of novel sezary syndrome genes in mycosis fungoides reveals genes common across stages and those associated with advanced stages
- Mogamulizumab in combination improves clinical outcomes in relapsed and refractory Sézary syndrome
- Cutaneous T-Cell Lymphoma (CTCL) Arising Post Kidney Transplant: A Review of Clinical Variants in the Literature
- Not a Cyst: When a Cyst Obscures a More Nefarious Process
- Cutaneous T-Cell Lymphoma (CTCL) Arising Post Kidney Transplant: A Review of Clinical Variants in the Literature
- Mogamulizumab in combination improves clinical outcomes in relapsed and refractory Sézary syndrome
- Not a Cyst: When a Cyst Obscures a More Nefarious Process
- Not a Cyst: When a Cyst Obscures a More Nefarious Process
- Mogamulizumab in combination improves clinical outcomes in relapsed and refractory Sézary syndrome
- Mogamulizumab in combination improves clinical outcomes in relapsed and refractory Sézary syndrome
Similar Researchers
Based on overlapping research topics